Rennova Health, Inc. RNVA
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | 19.59M | 16.81M | 13.04M | 9.51M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 19.59M | 16.81M | 13.04M | 9.51M |
| Cost of Revenue | -- | 7.51M | 7.25M | 6.77M | 5.99M |
| Gross Profit | -- | 12.08M | 9.56M | 6.27M | 3.52M |
| SG&A Expenses | -- | 8.33M | 7.85M | 7.21M | 5.85M |
| Depreciation & Amortization | -- | 428.80K | 446.60K | 469.30K | 481.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | 16.27M | 15.55M | 14.45M | 12.32M |
| Operating Income | -- | 3.32M | 1.26M | -1.41M | -2.81M |
| Income Before Tax | -- | 2.41M | 110.00K | -2.96M | -4.83M |
| Income Tax Expenses | -- | 829.80K | 312.80K | 312.80K | 179.50K |
| Earnings from Continuing Operations | -- | 1.58 | -0.20 | -3.27 | -5.01 |
| Earnings from Discontinued Operations | -- | -21.20K | -17.00K | -18.40K | -9.60K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 1.40K | -- | -- | -- |
| Net Income | -- | 1.56M | -219.90K | -3.29M | -5.02M |
| EBIT | -- | 3.32M | 1.26M | -1.41M | -2.81M |
| EBITDA | -- | 3.75M | 1.71M | -940.20K | -2.33M |
| EPS Basic | -- | 0.00 | -0.11 | -28.83 | -74.56 |
| Normalized Basic EPS | -- | 0.00 | 0.00 | -0.34 | -0.18 |
| EPS Diluted | -- | 0.00 | -0.11 | -28.83 | -74.56 |
| Normalized Diluted EPS | -- | 0.00 | 0.00 | -0.34 | -0.18 |
| Average Basic Shares Outstanding | -- | 97.84B | 69.60B | 39.85B | 12.28B |
| Average Diluted Shares Outstanding | -- | 1.03T | 549.66B | 39.85B | 12.28B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |